| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |